01 — The Text
What.
- Extends the Kay Hagan Tick Act, which funds research into tick-borne illnesses like Lyme disease.
- Detailed provisions pending—official summary not yet published by Congressional Research Service.
- Passed committee unanimously (48-0), indicating broad bipartisan support for the measure.
02 — The Stakes
So what?
- Affects public health researchers, medical institutions, and the estimated 476,000 Americans diagnosed with Lyme disease annually.
- Ensures continued federal funding for prevention, detection, and treatment of tick-borne diseases.
- No apparent tradeoffs or opposing groups—unanimous committee vote suggests consensus on disease research value.
03 — The Path
Now what?
- Bill passed committee in May 2026 and was formally reported in July. Next: full House floor vote.
- With 36 cosponsors and unanimous committee approval, passage is likely but not guaranteed.
- Track progress at Congress.gov; contact your House representative to express support or concerns.
Legislative History
Actions.
- Jul 2, 2026 — Placed on the Union Calendar, Calendar No. 630.
- Jul 2, 2026 — Reported by the Committee on Energy and Commerce. H. Rept. 119-725.
- Jul 2, 2026 — Reported by the Committee on Energy and Commerce. H. Rept. 119-725.
- May 21, 2026 — Ordered to be Reported by the Yeas and Nays: 48 - 0.
- May 21, 2026 — Committee Consideration and Mark-up Session Held
- May 13, 2026 — Forwarded by Subcommittee to Full Committee by Voice Vote.
- May 13, 2026 — Subcommittee Consideration and Mark-up Session Held
- Jul 10, 2025 — Referred to the House Committee on Energy and Commerce.